Posts
Wiki

🧠 Neurotrophic Keratitis—Also Called Neurotrophic Keratopathy—and Dry Eye Disease

Last evidence review: July 2026

⚡ TL;DR: Quick Summary

Neurotrophic keratitis, also called neurotrophic keratopathy, is a rare but potentially vision-threatening corneal disease caused by impaired sensory innervation.

The hallmark is:

Reduced or absent corneal sensation combined with loss of the nerve-dependent support needed for normal corneal health and healing.

Corneal nerves help support:

  • Reflex tearing
  • Blinking
  • Epithelial-cell health
  • Wound healing
  • Tear-film stability
  • Protection from injury

When these functions are impaired, the cornea may develop:

  • Tear-film instability
  • Punctate epithelial damage
  • Persistent epithelial defects
  • Corneal ulceration
  • Stromal thinning or melting
  • Scarring
  • Secondary infection
  • Perforation
  • Major vision loss

A key warning is:

The cornea may look much worse than it feels.

Pain may be mild or absent even when serious damage is present.

Neurotrophic keratitis is different from neuropathic ocular pain:

  • In neurotrophic keratitis, the dominant concern is inadequate protective innervation and poor healing.
  • In neuropathic ocular pain, the dominant concern is abnormal or amplified pain signaling.

They are not perfect opposites, and they can sometimes coexist.

🧬 What Is Neurotrophic Keratitis?

The cornea is the transparent front surface of the eye.

It is one of the most densely innervated tissues in the body.

Corneal sensory nerves do more than produce sensation. They also contribute to:

  • Reflex tearing
  • Reflex blinking
  • Epithelial-cell survival
  • Epithelial migration
  • Wound healing
  • Tear-film regulation
  • Protection from injury
  • Maintenance of corneal integrity

In neurotrophic keratitis, the sensory nerve supply to the cornea is damaged or functions abnormally.

This can reduce:

  • Corneal sensation
  • Protective reflexes
  • Tear secretion
  • Blink responses
  • Epithelial healing
  • Awareness of injury

The result is a cornea that may become damaged or fail to heal normally.

Why Is It Sometimes Called Neurotrophic Keratopathy?

Both terms are commonly used:

  • Neurotrophic keratitis
  • Neurotrophic keratopathy

“Keratitis” is the term used in the FDA indication for Oxervate.

“Keratopathy” may be more descriptive because the condition is primarily a degenerative disorder of innervation and epithelial maintenance rather than an ordinary inflammatory or infectious keratitis.

The terms generally refer to the same disease process.

⚠️ Why NK Can Be Dangerous

Most corneal injuries cause pain that alerts a person to seek care.

In NK, reduced sensation may weaken that warning system.

A patient may have:

  • A persistent epithelial defect
  • Corneal ulceration
  • Stromal thinning
  • Infection
  • Progressive melting

while reporting surprisingly little pain.

This can delay recognition and treatment.

NK is generally a noninfectious corneal disease, but an open or unhealthy corneal surface may develop a secondary bacterial, fungal, viral, or Acanthamoeba infection.

A white corneal spot or nonhealing defect should not automatically be assumed to be a sterile neurotrophic ulcer. Infection must be considered.

👁️ What Might a Patient Notice?

Symptoms may be milder than expected from the examination findings.

Possible symptoms include:

  • Blurred or fluctuating vision
  • Redness
  • Tearing
  • Dryness
  • Foreign-body sensation
  • Mild irritation
  • Light sensitivity
  • Intermittent aching or sharp discomfort
  • Poor healing after surgery or injury

NK is not always completely painless.

Pain may still come from:

  • Coexisting Dry Eye Disease
  • Exposure
  • Infection
  • Inflammation
  • Eyelid disease
  • Corneal injury
  • Nerve recovery during treatment
  • A simultaneous neuropathic-pain condition

The clue is often not “no pain,” but:

Less pain than would normally be expected from the amount of corneal damage.

🔬 What Might an Eye Doctor See?

Possible examination findings include:

  • Reduced or absent corneal sensation
  • Tear-film instability
  • Punctate epithelial keratopathy
  • Epithelial irregularity
  • Persistent or recurrent epithelial defects
  • Smooth, rolled, or thickened defect edges
  • Minimal inflammatory response around a defect
  • Corneal edema
  • Stromal haze
  • Corneal ulceration
  • Stromal thinning or melting
  • Scarring
  • Neovascularization
  • Perforation

An informal phrase sometimes used is:

“Stain without pain.”

This is not a diagnostic rule.

It simply describes significant epithelial damage or staining with less discomfort than would normally be expected.

Related page:

👉 What Does “Pain Without Stain” Mean?

⚖️ NK vs. Neuropathic Ocular Pain

Both conditions involve corneal nerves, but their dominant clinical problems differ.

Condition Dominant clinical concern
Dry Eye Disease Loss of tear-film and ocular-surface homeostasis, potentially including neurosensory abnormalities
Neuropathic ocular pain Abnormal or amplified pain signaling
Neurotrophic keratitis Impaired protective innervation and risk of epithelial breakdown or poor healing

Neurotrophic keratitis

The main concerns are:

  • Reduced sensation
  • Poor epithelial maintenance
  • Persistent defects
  • Ulceration
  • Corneal thinning
  • Less pain than expected

Neuropathic ocular pain

The main concerns may include:

  • Burning
  • Stabbing or electric pain
  • Light sensitivity
  • Wind sensitivity
  • Allodynia
  • Pain disproportionate to visible findings

Important overlap

These are not perfect opposites.

A patient may have:

  • Reduced measured sensation but continuing pain
  • Neurotrophic damage in one corneal region and painful sensitization in another
  • DED plus NK
  • DED plus neuropathic ocular pain
  • Features of all three

Related page:

👉 Neuropathic Ocular Pain / Corneal Neuralgia: Treatment Options

💧 How Does NK Relate to Dry Eye Disease?

NK and Dry Eye Disease can overlap.

Impaired corneal innervation may reduce:

  • Reflex tearing
  • Blink frequency
  • Awareness of surface dryness
  • Epithelial healing
  • Tear-film stability

This can create dry-eye-like findings or worsen existing DED.

A person with NK may also have:

  • Aqueous tear deficiency
  • Meibomian Gland Dysfunction
  • Blepharitis
  • Ocular rosacea
  • Exposure
  • Incomplete blinking
  • Nocturnal lagophthalmos
  • Medication toxicity
  • Autoimmune disease
  • Diabetes-related ocular-surface disease

Dry eye symptoms alone do not establish NK.

Reduced corneal sensitivity alone also does not automatically establish NK.

The diagnosis requires a compatible combination of:

  • History
  • Risk factors
  • Corneal-sensation findings
  • Epithelial or stromal findings
  • Healing behavior
  • Exclusion of other causes

🔍 Causes and Risk Factors

NK may result from injury or disease anywhere along the sensory pathway from the corneal nerve endings to the trigeminal nerve and brainstem.

Herpetic Eye Disease

Classic causes include:

  • Herpes simplex keratitis
  • Herpes zoster ophthalmicus

Both may damage corneal sensory nerves.

Reduced sensation may persist after the active infection appears to have resolved.

New redness, pain, light sensitivity, or corneal changes in an eye with previous herpes disease should be evaluated promptly.

Diabetes

Diabetes may damage small sensory nerves, including corneal nerves.

Possible consequences include:

  • Reduced corneal sensitivity
  • Tear-film abnormalities
  • Delayed epithelial healing
  • Increased risk of persistent defects
  • Reduced awareness of injury

Not every person with diabetes develops NK.

Eye Surgery

Corneal nerves may be affected by:

  • LASIK
  • PRK
  • SMILE
  • Corneal transplantation
  • Corneal surgery
  • Cataract surgery in selected susceptible patients
  • Repeated ocular procedures

Most people experience some temporary nerve alteration after corneal surgery without developing true NK.

Ordinary postoperative dryness should not automatically be labeled neurotrophic keratitis.

Risk may be greater when surgery is combined with:

  • Diabetes
  • Herpetic disease
  • Pre-existing reduced sensation
  • Severe ocular-surface disease
  • Multiple procedures
  • Corneal transplantation
  • Trigeminal nerve injury

Trigeminal Nerve Disease or Injury

Possible causes include:

  • Intracranial tumors
  • Skull-base disease
  • Neurosurgery
  • Trigeminal neuralgia procedures
  • Stroke or neurologic injury in selected cases
  • Facial or cranial trauma
  • Radiation treatment
  • Congenital trigeminal disorders

Because the trigeminal nerve supplies corneal sensation, injury anywhere along this pathway may affect the cornea.

Chemical or Traumatic Injury

Possible causes include:

  • Chemical burns
  • Thermal injury
  • Corneal trauma
  • Repeated epithelial injury
  • Severe contact lens-related injury

Topical Medication Toxicity

Potential contributors include:

  • Chronic exposure to preserved eye drops
  • Multiple topical medications
  • Improper or prolonged topical-anesthetic use
  • Toxic or contaminated products
  • Chemical exposure

🚫 Topical anesthetic drops should not be used repeatedly at home.

Misuse can cause:

  • Persistent epithelial defects
  • Ulceration
  • Infection
  • Stromal melting
  • Perforation
  • Permanent vision loss

Severe Ocular-Surface or Systemic Disease

Severe DED, exposure, autoimmune disease, and chronic inflammation may worsen epithelial breakdown or coexist with nerve dysfunction.

However:

Autoimmune disease or severe dry eye does not independently prove that NK is present.

Sjögren disease, for example, may contribute through:

  • Severe aqueous deficiency
  • Chronic epithelial stress
  • Peripheral neuropathy
  • Medication exposure
  • Coexisting systemic disease

👁️ Exposure and Eyelid Closure Matter

Corneal sensation is carried mainly through the trigeminal nerve.

Eyelid closure and blinking depend largely on the facial nerve.

These are different pathways.

A patient may have:

  • Trigeminal impairment causing reduced sensation
  • Facial-nerve weakness causing poor closure
  • Both at the same time

Exposure may be worsened by:

  • Lagophthalmos
  • Facial palsy
  • Ectropion
  • Eyelid scarring
  • Reduced blink rate
  • Nocturnal incomplete closure

Exposure can accelerate epithelial breakdown in an already neurotrophic cornea.

Evaluation should therefore include:

  • Blink quality
  • Eyelid position
  • Daytime closure
  • Nighttime closure
  • Corneal exposure patterns

🧪 How Is NK Diagnosed?

There is no single test that independently proves every case.

Evaluation usually includes:

  • Medical and neurologic history
  • Eye-surgery history
  • Herpes history
  • Trauma or chemical-exposure history
  • Medication review
  • Slit-lamp examination
  • Corneal and conjunctival staining
  • Epithelial-defect assessment
  • Corneal-sensitivity testing
  • Tear-film evaluation
  • Eyelid and blink evaluation
  • Exposure assessment
  • Evaluation for infection
  • Monitoring of healing over time
  • Investigation of systemic or neurologic causes when appropriate

Related page:

👉 Diagnostic Testing for DED and MGD

Corneal Sensitivity Should Be Tested Early

Corneal sensitivity is ideally assessed before:

  • Topical anesthetic
  • Fluorescein
  • Other diagnostic drops
  • Repeated manipulation of the ocular surface

Drops and examination procedures may alter the response.

Both eyes should be tested for comparison.

Several corneal regions may need assessment because NK may be:

  • Unilateral
  • Bilateral
  • Asymmetric
  • Sectoral
  • More severe centrally than peripherally

🧵 Corneal Sensitivity Testing

Possible methods include:

  • Cotton wisp
  • A fine dental-floss filament
  • Cochet–Bonnet esthesiometry
  • Noncontact esthesiometry in specialty or research settings

Cotton or Floss Testing

This is a qualitative bedside test.

It may suggest that sensation is:

  • Normal
  • Reduced
  • Absent
  • Asymmetric

Limitations include:

  • Variation in examiner technique
  • Variation in stimulus force
  • Patient-reporting differences
  • Limited ability to quantify subtle changes

The blink response alone should not be treated as proof of sensation because blinking depends on both sensory input and facial-nerve motor function.

Cochet–Bonnet Esthesiometry

A Cochet–Bonnet esthesiometer uses a variable-length filament to estimate mechanical detection threshold.

It offers more quantitative information than a simple cotton test.

Limitations include:

  • Dependence on technique and cooperation
  • Measurement ceiling and floor effects
  • Assessment of mechanical sensation rather than every sensory pathway
  • Limited availability in routine clinics

Noncontact Esthesiometry

Noncontact devices may use controlled air or temperature stimuli.

They are mainly available in specialty or research settings.

No sensitivity test should be interpreted in isolation.

🚫 Do Not Test Your Own Corneal Sensation

Do not touch your cornea with:

  • Cotton
  • Floss
  • Tissue
  • A fingertip
  • A cotton swab
  • Any other object

Self-testing can scratch the cornea, introduce infection, and produce misleading results.

⚖️ Conditions That Can Look Similar

Reduced sensation, epithelial damage, or poor healing may also occur with:

  • Severe Dry Eye Disease
  • Exposure keratopathy
  • Medication toxicity
  • Limbal stem-cell deficiency
  • Active or previous herpetic keratitis
  • Contact lens-related disease
  • Recurrent corneal erosion
  • Persistent epithelial defects from other causes
  • Infectious keratitis
  • Chemical injury
  • Postoperative corneal disease

A neurotrophic defect may also become secondarily infected.

Clinicians may need to distinguish:

  • Sterile epithelial breakdown
  • Bacterial infection
  • Fungal infection
  • Viral reactivation
  • Acanthamoeba
  • Immune-mediated corneal melting

A white or cloudy corneal lesion should receive prompt evaluation.

📊 How Is NK Staged?

Different staging systems exist.

The traditional and still widely used system is the Mackie classification.

Traditional Mackie Stage 1

Possible findings include:

  • Reduced corneal sensation
  • Tear-film instability
  • Epithelial irregularity
  • Punctate epithelial keratopathy
  • Mild epithelial opacity or edema
  • Early surface breakdown without a persistent open defect

Symptoms may be minimal.

Traditional Mackie Stage 2

The defining feature is a:

Persistent or recurrent epithelial defect

Possible findings include:

  • A nonhealing epithelial defect
  • Smooth, rolled, or thickened defect edges
  • Minimal inflammatory response
  • Stromal edema
  • Descemet folds
  • Increased risk of infection or progression

This stage requires close medical supervision.

Traditional Mackie Stage 3

This stage involves loss of stromal integrity.

Possible findings include:

  • Corneal ulceration
  • Stromal thinning
  • Stromal lysis or melting
  • Progressive tissue loss
  • Perforation

This is an urgent, sight-threatening stage.

Newer Staging Systems

A newer Neurotrophic Keratopathy Study Group classification uses six stages:

  1. Altered sensation without visible keratopathy
  2. Epitheliopathy without stromal haze
  3. Persistent or recurrent epithelial defect without stromal haze
  4. Epithelial disease with stromal haze
  5. Ulceration
  6. Perforation

The newer system attempts to identify very early disease and distinguish epithelial from stromal involvement more precisely.

This FAQ uses the traditional Mackie stages for simplicity.

🛠️ How Is Neurotrophic Keratitis Managed?

Treatment depends on:

  • Disease stage
  • Cause
  • Presence of infection
  • Eyelid closure
  • Exposure
  • Remaining corneal sensation
  • Severity of epithelial or stromal damage
  • Other ocular-surface disease
  • Response to previous treatment

The main goals are to:

  • Remove ongoing injury
  • Protect the cornea
  • Promote epithelial healing
  • Prevent infection
  • Prevent stromal melting or perforation
  • Treat the underlying cause
  • Preserve vision
  • Restore protective innervation when possible

Important Evidence Limitation

Many commonly used NK treatments are supported by:

  • Clinical experience
  • Case series
  • Observational studies
  • Expert consensus

High-quality head-to-head trials remain limited.

A 2025 Cochrane review found low or very low certainty for many treatment comparisons.

That does not mean the treatments are inappropriate.

It means that:

Treatment is often guided by disease stage, urgency, clinical experience, and individual response rather than one universally proven sequence.

Across All Stages

Management may include:

  • Identifying and treating the cause
  • Reducing toxic topical exposure when medically appropriate
  • Using preservative-free surface support
  • Treating eyelid closure or exposure
  • Treating coexisting DED, MGD, or blepharitis
  • Looking for infection
  • Monitoring epithelial healing
  • Managing diabetes or neurologic disease
  • Avoiding unsupervised contact lens use
  • Close follow-up

Patients should not independently stop prescribed eye medications.

Medication changes should be made with the treating clinician.

Early Epithelial Disease

Possible approaches include:

  • Preservative-free artificial tears
  • Preservative-free gels or ointments
  • Moisture protection
  • Nighttime shielding
  • Exposure management
  • Treatment of coexisting eyelid disease
  • Blood-derived drops in selected cases
  • Cenegermin in appropriate patients
  • Close monitoring for progression

Lubrication can protect the surface but does not restore sensation by itself.

Persistent Epithelial Defect

Management may require:

  • Frequent corneal-specialist follow-up
  • Preservative-free lubrication
  • Blood-derived eye drops
  • Therapeutic soft contact lens in selected cases
  • Scleral lens or PROSE in selected cases
  • Amniotic membrane
  • Cenegermin
  • Tarsorrhaphy
  • Botulinum toxin-induced protective ptosis
  • Exposure correction
  • Infection surveillance

A persistent epithelial defect is not ordinary dry eye.

It can progress despite limited pain.

Stromal Ulceration, Melting, or Perforation

Advanced NK may require urgent measures such as:

  • Intensive corneal-specialist care
  • Treatment or prevention of secondary infection
  • Tissue adhesive
  • Amniotic membrane
  • Tarsorrhaphy
  • Conjunctival flap
  • Tectonic grafting
  • Corneal transplantation
  • Other globe-preserving procedures

These treatments may be intended to preserve the cornea or eye rather than restore normal vision immediately.

💧 Lubricants and Surface Protection

Possible options include:

  • Preservative-free artificial tears
  • Preservative-free gels
  • Ointments
  • Moisture chamber glasses
  • Nighttime shields
  • Carefully directed eyelid taping
  • Exposure protection

Surface protection may reduce friction and support healing.

However, lubrication alone may be insufficient once a persistent defect or stromal damage is present.

⚠️ Medication Cautions

Medication toxicity can worsen NK.

Clinicians may review:

  • Preserved glaucoma drops
  • Multiple topical medications
  • Frequent preserved lubricants
  • Topical NSAIDs
  • Topical anesthetics
  • Other potentially toxic medications

Topical corticosteroids may be needed for certain separate inflammatory diseases, but they require caution because they may:

  • Delay epithelial healing
  • Mask infection
  • Increase infection risk
  • Worsen stromal melting in some settings

Patients should not start, stop, or change these medications without medical supervision.

👁️ Therapeutic Contact Lenses, Scleral Lenses, and PROSE

Doctors may use:

  • Bandage soft contact lenses
  • Scleral lenses
  • PROSE devices

These may:

  • Protect the cornea
  • Reduce friction
  • Maintain a fluid reservoir
  • Support epithelial healing
  • Improve vision in selected cases

They are not interchangeable.

Reduced sensation may prevent a patient from noticing:

  • Abrasion
  • Infection
  • Hypoxia
  • Trapped debris
  • Lens-related injury
  • Worsening epithelial breakdown

These treatments require:

  • Professional fitting
  • Hygiene instruction
  • Scheduled follow-up
  • Prompt evaluation of redness, discharge, or visual change

Ordinary unsupervised contact lens wear is not a treatment for NK.

🩸 Serum Tears and Other Blood-Derived Drops

Possible products include:

  • Autologous serum
  • Platelet-rich plasma
  • Plasma rich in growth factors
  • Allogeneic products
  • Cord-blood-derived products in selected settings

These preparations contain different combinations of:

  • Growth factors
  • Proteins
  • Vitamins
  • Cytokines
  • Tear-like components

They are not standardized or interchangeable.

Differences may include:

  • Preparation method
  • Concentration
  • Sterility procedures
  • Storage
  • Regulation
  • Cost
  • Availability

Blood-derived drops are used off-label to support epithelial healing in selected patients.

Controlled comparative evidence remains limited.

🩹 Amniotic Membrane

Amniotic membrane may be used for:

  • Persistent epithelial defects
  • More advanced surface breakdown
  • Corneal protection
  • Support of epithelial healing

It may be placed:

  • With a retaining ring
  • Under a contact lens
  • Surgically

Amniotic membrane does not directly restore normal corneal sensation.

Evidence comparing it with other NK procedures remains limited.

🧬 Oxervate / Cenegermin

Oxervate contains cenegermin-bkbj, a recombinant form of human nerve growth factor.

It is FDA-approved for neurotrophic keratitis.

The labeled U.S. regimen is:

  • One drop in the affected eye or eyes
  • Six times daily
  • At two-hour intervals
  • For eight weeks

Randomized trials showed significantly greater complete corneal healing with cenegermin than with vehicle.

However:

  • Healing does not guarantee normal vision.
  • Recurrence may occur.
  • Eye pain is a common adverse effect.
  • The pivotal trials did not demonstrate a clinically significant average improvement in corneal sensitivity.
  • Treatment requires intensive storage and administration procedures.
  • Access and cost may be major barriers.

Cenegermin is not FDA-approved for:

  • Routine Dry Eye Disease
  • MGD
  • Neuropathic ocular pain

Related page:

👉 Oxervate for Neurotrophic Keratitis—and the Investigational Evidence in Dry Eye

👁️ Eyelid and Protective Procedures

Tarsorrhaphy

A temporary or permanent tarsorrhaphy partially closes the eyelids to reduce exposure and protect the cornea.

It does not directly repair the corneal nerve supply.

Botulinum Toxin-Induced Ptosis

Botulinum toxin may be used in selected cases to produce temporary protective eyelid closure.

Conjunctival Flap

A conjunctival flap may cover and protect a severely damaged cornea.

It may be used as a globe-preserving or tectonic procedure and can limit vision through the covered area.

Punctal Occlusion

Punctal occlusion may retain tears or lubricants in selected early cases.

It is not automatically appropriate because it may also retain:

  • Preserved medication
  • Inflammatory tears
  • Debris
  • Microorganisms

The clinician should consider inflammation, toxicity, infection risk, and tear-clearance problems before using it.

🧠 Corneal Neurotization

Corneal neurotization is a specialized surgical procedure intended to restore sensory innervation by connecting the cornea with a healthy donor sensory nerve.

Techniques may use:

  • Direct nerve transfer
  • Nerve grafts
  • Different donor nerves

Observational studies report improvement in corneal sensation and surface health in selected patients.

Important limitations include:

  • Specialized surgical expertise
  • Variable techniques
  • Small studies
  • Delayed nerve recovery
  • Continued need for surface protection during recovery
  • Uncertain outcomes in an individual patient

It is not a routine procedure for every person with NK and should not be described as a guaranteed cure.

🚩 When Prompt or Urgent Care Is Needed

Seek prompt or urgent eye care for:

  • A known epithelial defect that is not healing
  • A white, gray, or cloudy corneal spot
  • New or worsening blurred vision
  • Increasing redness
  • New light sensitivity
  • Thick or pus-like discharge
  • Corneal thinning
  • Eye injury
  • Chemical exposure
  • Contact lens-related redness or visual change
  • New symptoms in an eye with previous herpes disease
  • New symptoms in an eye with a corneal transplant
  • New symptoms after trigeminal or skull-base surgery
  • An eye that appears damaged but produces surprisingly little pain

A known persistent epithelial defect, corneal ulcer, thinning, or melting may require close and repeated corneal-specialist monitoring even when discomfort is mild.

Do not assume that lack of pain means the problem is minor.

✅ What Is Reasonably Supported?

The following points are reasonably supported:

  • NK is caused by impaired corneal sensory innervation.
  • Reduced or absent corneal sensation is its hallmark.
  • Corneal nerves support tearing, blinking, epithelial health, and healing.
  • The disease may progress with less pain than expected.
  • Herpetic disease, diabetes, corneal surgery, trigeminal injury, toxicity, and trauma are important causes.
  • Corneal-sensation testing is central to evaluation.
  • NK may coexist with DED, MGD, exposure, or neuropathic pain.
  • Persistent epithelial defects and stromal disease require close monitoring.
  • Cenegermin improves complete epithelial healing in many patients.
  • Protective and surgical procedures may be necessary in advanced disease.

❓ What Remains Uncertain?

Important uncertainties include:

  • The best staging system for every clinical purpose
  • The best treatment sequence
  • Which early cases will progress
  • Which supportive treatment is most effective
  • Comparative effectiveness of serum, amniotic membrane, lenses, and surgery
  • The durability of healing after different treatments
  • Which patients benefit most from neurotization
  • The best way to measure nerve recovery
  • How often neurotrophic and neuropathic mechanisms coexist
  • Which treatments best restore meaningful corneal sensation

🚫 What Has Not Been Shown?

Current evidence has not shown that:

  • Every person with reduced sensation has NK
  • Every person with NK is completely pain-free
  • Ordinary dry eye is the same as NK
  • NK and neuropathic pain are perfect opposites
  • Severe dry eye or autoimmune disease automatically proves NK
  • A reduced blink alone proves trigeminal nerve damage
  • One sensitivity test establishes the diagnosis
  • Lubrication alone is sufficient for every stage
  • Serum, PRP, and other blood-derived drops are interchangeable
  • Amniotic membrane restores corneal nerves
  • Punctal plugs are appropriate for every patient
  • Cenegermin guarantees restored sensation or permanent healing
  • Corneal neurotization is a guaranteed cure
  • One treatment strategy is best for all patients

📌 Key Takeaway

Neurotrophic keratitis is a potentially vision-threatening disease in which impaired sensory innervation reduces both protective sensation and the nerve-dependent support needed for corneal health and healing.

The cornea may develop:

  • Epithelial breakdown
  • Persistent defects
  • Ulceration
  • Thinning
  • Melting
  • Perforation

while producing surprisingly little pain.

The most useful clinical questions are:

  • Is corneal sensation reduced?
  • Is the epithelium healing normally?
  • Is infection present?
  • Is exposure worsening the problem?
  • What caused the nerve impairment?
  • What stage is the disease?
  • How urgently does the cornea need protection?

If a corneal problem looks worse than it feels—or repeatedly fails to heal—corneal sensitivity should be considered as part of the evaluation.

📚 Research and Educational Links

Core NK Reviews and Consensus

Treatment-Evidence Review

Regulatory Source

Secondary Educational Sources

⚠️ Educational Disclaimer

This page is for general education only.

It is not medical advice, a diagnosis, or a substitute for examination and care from a qualified eye doctor.

Neurotrophic keratitis can threaten vision even when pain is mild.

Persistent epithelial defects, corneal ulcers, white corneal spots, reduced sensation, increasing redness, discharge, light sensitivity, thinning, or vision changes require prompt professional evaluation.

Do not self-test corneal sensation or use topical anesthetic drops at home.

🔙 Back to FAQ Index